Skip to content

ACUTUS MEDICAL

Active Public limited companyfounded 2013active for 13 yearsUitbreidingstraat 84, 2600 AntwerpKBO/BCE: BE 0537.488.183 subsidiary of ACUTUS MEDICAL, INC.

Lifetime

12 annual accounts with figures on one time axis
Gross marginpeak €5.9m (2021)
-€15,957 
Resultlowest -€887,820 (2015)
-€30,826▼ €128,173
Equitypeak €638,479 (2022)
€378,368▼ 7.5%
Debts
€1,462▼ 95.5%
Staffpeak 24.9 FTE (2021)
0 FTE▼ 100%
Board8 names since 2021
2 directorsTakeo MUKAI and 1 other
Owners
  
Documentsfilings and deeds
05-08-20265 days late
2025financial year
Loss of €30,826Staff from 3 FTE to 0 FTEDebts from €32,822 to €1,462Cash from €659 to €4,269

Key points

from the 2025 annual accounts

Equity

€378,368 from €638,479 in 2022

Equity fell by 41% in 3 years.

Staff

0 FTE ▼ 100%
3202402025

Fewer staff in 2025 from 3 FTE to 0 FTE.

At the same address

152 companies
  • VT Build seat since 09-10-2026
  • MWL EUROPE seat since 05-10-2026
  • Domek Belgium seat since 15-09-2026
2025 accounts filed 5 days after the deadline

Checked score

88
Excellent
Financially stronger than 47% of micro companies in other manufacturing (NACE 32)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: 0.3% across 1,141 companies (NACE 32, micro).

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.7% 01-2025: 0.7%● unchanged vs 12-2024 02-2025: 0.6%▼ -0.1 percentage points vs 01-2025 03-2025: 0.6%● unchanged vs 02-2025 04-2025: 0.7%▲ +0.1 percentage points vs 03-2025 05-2025: 0.9%▲ +0.2 percentage points vs 04-2025 06-2025: 0.9%● unchanged vs 05-2025 07-2025: 0.9%● unchanged vs 06-2025 08-2025: 1.4%▲ +0.5 percentage points vs 07-2025 09-2025: 1.8%▲ +0.4 percentage points vs 08-2025highest value 10-2025: 0.6%▼ -1.2 percentage points vs 09-2025 11-2025: 0.6%● unchanged vs 10-2025 12-2025: 0.6%● unchanged vs 11-2025 01-2026: 0.6%● unchanged vs 12-2025 02-2026: 0.6%● unchanged vs 01-2026 03-2026: 0.6%● unchanged vs 02-2026 04-2026: 0.6%● unchanged vs 03-2026 05-2026: 0.7%▲ +0.1 percentage points vs 04-2026 06-2026: 0.7%● unchanged vs 05-2026 07-2026: 0.7%● unchanged vs 06-2026 08-2026: 1.1%▲ +0.4 percentage points vs 07-2026 09-2026: 0.2%▼ -0.9 percentage points vs 08-2026lowest value 10-2026: 0.2%● unchanged vs 09-2026lowest value 11-2026: 0.2%● unchanged vs 10-2026lowest value

Financial strength
Average

Solvency
100=equity 99.6% of total assets
Liquidity
51+1short-term debt 0.4% · cash 1.1%
Profitability
17-29return on assets -8.1%

Score breakdown

raises risk
Loss of €30,826 (financial year 2025)
Liquidity: current ratio 259.80, cash €4,269
lowers risk
Founded in 2013
Equity €378,368 (99.6% of total assets)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro). It does better than 90% of them on solvency, 48% on liquidity, 20% on profitability and 29% on growth.

The bankruptcy probability was computed on 05-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 6,908 companies had the same profile as ACUTUS MEDICAL has now. Each dot stands for 18 companies, two years later.

90.9%
were still trading
7.8%
stopped another way
1.1%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a small loss

Another 0.2% stopped without a precise date, possibly only after those two years.

That fits the bankruptcy probability of ACUTUS MEDICAL itself: 0.2% within 12 months.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,908 companies, not a prediction for ACUTUS MEDICAL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €30,000 on 30-day terms is acceptable

Short-term debt is 0.4% and cash 1.1% of total assets. 0.4% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
raises risk · Loss of €30,826 (financial year 2025)
NBB · annual accounts
lowers risk · Founded in 2013
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Equity €378,368 (99.6% of total assets)
NBB · annual accounts
raises risk · Liquidity: current ratio 259.80, cash €4,269
NBB · annual accounts
raises risk · 2025 accounts filed 5 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-08-2026, 5 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
5 days late
2024
26 days late
2023
57 days early
2022
7 days early
2021
11 days early
2020
61 days late
2019
46 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 9 days after the deadline. In the sector (NACE 32), the median for financial year 2024 was 2 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 24 July (4 of the last 5 accounts filed within 33 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

CH
Managing director
TM
Director, since 15-12-2023
  • ACUTUS MEDICAL, INC. consolidatesannual accounts 2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0537488183
Registered office moved from Zaventem to Antwerp New registered office: Uitbreidingstraat 84/3, 2600 Antwerpen · Previous registered office: Ikaroslaan 25, 1930 Zaventem · Resignation: Jayesh Purbhoo (managing director) · General meeting of 30-06-2024 · Gazette deed
Resignation: David ROMAN (director) Appointment: Takeo MUKAI (director) · General meeting of 15-12-2023 · Gazette deed
1 director resigning, 2 reappointments Resignation: Mathew POWELL · Reappointments: Jayesh PURBHOO (managing director) and David ROMAN · The company holds all the shares of ACUTUS MEDICAL · General meeting of 18-10-2023 · Gazette deed
All 31 events

Comparable companies

same main activity, similar in size and age
Company Total assets Gross margin Solvency Staff
ACUTUS MEDICAL Antwerp €379,830 -€15,957 99.6% 0
LABORATOIRE DENTAIRE STEPHANE DUYSENS Verviers €274,899 -€15,195 98.8% -
CUSTOM SMILE DESIGN & CONSULTANCY Beveren-Kruibeke-Zwijndrecht €402,546 -€40,850 99.7% -
DYNAMIC DENTAL SERVICES Braine-l'Alleud €203,875 -€714 61.4% -
BoneCare Dynamics Zonhoven €167,500 -€94,115 -286.7% -
TCare Tielt €380,629 -€2,116 92.7% -
SW & CO Kontich €347,228 -€2,491 64.5% -

These companies have the same main activity as ACUTUS MEDICAL: manufacture of medical and dental instruments and supplies (NACE 32500). They are comparable in size and age: total assets between €167,000 and €403,000, founded between 1995 and 2020.

Official details

Source: KBO
Status
Active since 14-08-2013Normal situation
Registered office
153 active companies are registered at this address13 started in the 12 months before. Source: KBO register, as of 6 November 2026.
Activity
Manufacture of medical and dental instruments and suppliesNACE 32500and 3 others
Joint committee
200Auxiliary committee for white-collar workers · annual accounts 2024
Establishment unit
2.221.198.9411930 Zaventem, since 14-08-2013
Financial year end
31 December
Peppol
Reachable since 14-11-2025
Company details

Annual accounts 2025

Total assets
€379,830▼ 14.1%
Employeeson 31-12-2025
0
Filing
Filed on 05-08-2026
Financials

Insights on ACUTUS MEDICAL

Solvency rose in 2025 from 92.6% to 99.6% because of lower debts.

In August 2024, the Official Gazette published the appointment of Chad HOLLISTER as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ACUTUS MEDICAL

What is the company number of ACUTUS MEDICAL?
The company number of ACUTUS MEDICAL is 0537.488.183. The VAT number is the same number with BE in front: BE 0537.488.183.
Where is ACUTUS MEDICAL based?
The registered office is at Uitbreidingstraat 84, 2600 Antwerp.Company details
What does ACUTUS MEDICAL do?
According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
What is the legal form of ACUTUS MEDICAL?
ACUTUS MEDICAL is a public limited company (NV).
When was ACUTUS MEDICAL founded?
ACUTUS MEDICAL was founded on 14-08-2013.
Is ACUTUS MEDICAL still active?
Yes, ACUTUS MEDICAL is an active enterprise in the KBO register.
How many employees does ACUTUS MEDICAL have?
ACUTUS MEDICAL had an average of 3 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
Which joint committee does ACUTUS MEDICAL fall under?
In its 2024 annual accounts, ACUTUS MEDICAL states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of ACUTUS MEDICAL?
The annual accounts for financial year 2025 state no turnover. In financial year 2024 turnover was €0.
Is ACUTUS MEDICAL profitable?
In financial year 2025, ACUTUS MEDICAL made a loss of €30,826.
Where can I find the annual accounts of ACUTUS MEDICAL?
ACUTUS MEDICAL filed 12 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ACUTUS MEDICAL due?
ACUTUS MEDICAL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.